Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections
Armitage AE., Stacey AR., Giannoulatou E., Marshall E., Sturges P., Chatha K., Smith NMG., Huang X., Xu X., Pasricha S-R., Li N., Wu H., Webster C., Prentice AM., Pellegrino P., Williams I., Norris PJ., Drakesmith H., Borrow P.
Significance Altered iron levels correlate with disease progression in HIV type-1 (HIV-1) infection, and cellular iron promotes HIV-1 replication. In chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, increased liver iron levels contribute to disease. The peptide hormone hepcidin controls iron distribution. We find that hepcidin increases during the acute phase of HIV-1 infection, early hepcidin predicts later plasma viral set-point, and hepcidin remains high even in chronically infected individuals receiving antiretroviral therapy. Conversely hepcidin is not induced, and blood iron is not decreased, during the acute response to HBV and HCV. Therefore, the nature of iron redistribution during the response to infections is a pathogen-specific phenomenon; furthermore, the deleterious effects of chronic infection on hepcidin and iron appear to be established early in infection.